Teladoc to Acquire Livongo in $18.5 Billion Deal

Paul, Weiss is advising Teladoc Health, the global leader in virtual care, in its acquisition of Livongo, the leading Applied Health Signals company, in a cash-and-stock deal valued at $18.5 billion. The combination of these highly complementary leaders in virtual care and chronic condition management represents a transformational opportunity to improve the delivery, access and experience of healthcare worldwide.

Under the terms of the agreement, Teladoc shareholders will own approximately 58% of the combined company, while Livongo shareholders will own the remaining 42%. The combined company is expected to have more than $1.3 billion in pro forma revenue in 2020, representing year-over-year pro forma growth of 85%. The transaction is expected to close by the end of 2020, subject to regulatory approvals and other customary closing conditions.

The Paul, Weiss team includes, among others, corporate partners Scott Barshay, Laura Turano, Manuel Frey and John Kennedy, and counsel Patricia Vaz de Almeida; intellectual property partner Jonathan Ashtor; tax partner Robert Holo; employee benefits partner Jean McLoughlin and counsel Jarrett Hoffman; real estate partner Peter Fisch; litigation partner Audra Soloway and counsel Steven Herzog; and antitrust counsel Yuni Sobel.